Timothy G Johnstone

Title: Innovations and Contributions of Timothy G Johnstone

Introduction

Timothy G Johnstone is a notable inventor based in Seattle, WA, who has made significant contributions to the field of biotechnology. He holds two patents that focus on advanced therapeutic methods and binding molecules related to human health.

Latest Patents

One of his latest patents is for HPV-specific binding molecules. This patent provides binding molecules, such as T-cell receptors (TCRs) or antigen-binding fragments, that specifically recognize or bind to human papillomavirus (HPV) 16, including its E6 and E7 proteins. Additionally, the patent includes engineered cells containing these binding molecules, as well as compositions and methods of treatment involving their administration. Another significant patent by Johnstone is related to epigenetic analysis of cell therapy and associated methods. This patent outlines methods for identifying genomic regions that predict treatment outcomes with cell therapy. It includes epigenetic and epigenomic analyses of cells, which are crucial for preparing engineered cells for therapy and predicting their responses.

Career Highlights

Throughout his career, Timothy G Johnstone has worked with prominent companies in the biotechnology sector, including Juno Therapeutics GmbH and Editas Medicine, Inc. His work has focused on innovative approaches to cell therapy and molecular binding technologies.

Collaborations

Johnstone has collaborated with notable professionals in his field, including Cameron Brandt and Brian J Belmont. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Timothy G Johnstone's work exemplifies the intersection of innovation and biotechnology, particularly in the development of therapies targeting HPV and enhancing cell therapy outcomes. His contributions continue to impact the field significantly.